Up a level |
Rugo, H.S. and Rossi, G. and Rizzi, G. and Borroni, M.E. and Lorusso, V. and Kapthaus, M. and Bondarenko, I. and Sarosiek, T.J. and Aapro, M.S. (2013) NEPA, a fixed-dose combination of netupitant and palonosetron, prevents chemotherapy-induced nausea and vomiting (CINV) more effectively and reduces the impact on daily living for breast cancer patients compared with palonosetron. American Association for Cancer Research, 73 (Sup.24).